Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
DiaMedica Therapeutics Inc.:
We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated August 27, 2018, except for Note 1, as to which the date is November 19, 2018, with respect to the consolidated financial statements of DiaMedica Therapeutics Inc. included in its Registration Statement on Form S-1, as filed with the Securities and Exchange Commission.
| /s/ Baker Tilly Virchow Krause, LLP |
Minneapolis, Minnesota
December 14, 2018
